Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Frontiers in Bioscience (Landmark Edition)|January 7, 2014
Antibody-drug conjugates targeting prostate-specific membrane antigenWilliam C Olson, Robert J IsraelCurrent Opinion in Pharmacology|September 27, 2002
HIV entry inhibitors in clinical developmentBryan M O'Hara, William C OlsonCurrent Opinion in HIV and AIDS|April 3, 2009
CCR5 monoclonal antibodies for HIV-1 therapyWilliam C Olson, Jeffrey M JacobsonJournal of Pain Research|November 15, 2018
Oral methylnaltrexone is efficacious and well tolerated for the treatment of opioid-induced constipation in patients with chronic noncancer pain receiving concomitant methadoneLynn R Webster, Robert J IsraelJournal of Pain Research|August 28, 2018
Oral methylnaltrexone does not negatively impact analgesia in patients with opioid-induced constipation and chronic noncancer painLynn R Webster, Robert J IsraelExpert Opinion on Investigational Drugs|April 26, 2006
Methylnaltrexone, a novel peripheral opioid receptor antagonist for the treatment of opioid side effectsChun-Su Yuan, Robert J IsraelReviews on Recent Clinical Trials|May 14, 2008
Clinical trials of cancer therapies targeting prostate-specific membrane antigenWilliam C Olson, Warren D W Heston, Ayyappan K RajasekaranJournal of the American Academy of Dermatology|June 9, 2019
Immunogenicity and skin clearance recapture in clinical studies of brodalumabJerry Bagel, Mark Lebwohl, Robert J Israel, et al.Molecular Cancer Therapeutics|July 14, 2011
In vitro and in vivo responses of advanced prostate tumors to PSMA ADC, an auristatin-conjugated antibody to prostate-specific membrane antigenXinning Wang, Dangshe Ma, William C Olson, et al.Journal of Virology|January 15, 2005
Anti-CXCR4 monoclonal antibodies recognizing overlapping epitopes differ significantly in their ability to inhibit entry of human immunodeficiency virus type 1Xavier Carnec, Lan Quan, William C Olson, et al.Pageof 12